These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 22033682

  • 1. [Intraepithelial neoplasia of Barrett's esophagus: prognosis of potential malignancy].
    Werner M, Lassmann S.
    Pathologe; 2011 Nov; 32 Suppl 2():197-201. PubMed ID: 22033682
    [Abstract] [Full Text] [Related]

  • 2. Aurora kinase A in Barrett's carcinogenesis.
    Rugge M, Fassan M, Zaninotto G, Pizzi M, Giacomelli L, Battaglia G, Rizzetto C, Parente P, Ancona E.
    Hum Pathol; 2010 Oct; 41(10):1380-6. PubMed ID: 20656315
    [Abstract] [Full Text] [Related]

  • 3. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.
    Bani-Hani K, Martin IG, Hardie LJ, Mapstone N, Briggs JA, Forman D, Wild CP.
    J Natl Cancer Inst; 2000 Aug 16; 92(16):1316-21. PubMed ID: 10944553
    [Abstract] [Full Text] [Related]

  • 4. Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma.
    Walch A, Specht K, Braselmann H, Stein H, Siewert JR, Hopt U, Höfler H, Werner M.
    Int J Cancer; 2004 Dec 10; 112(5):747-53. PubMed ID: 15386389
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus.
    Dolan K, Morris AI, Gosney JR, Field JK, Sutton R.
    J Gastroenterol Hepatol; 2003 Jun 10; 18(6):683-9. PubMed ID: 12753151
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study.
    Klump B, Hsieh CJ, Holzmann K, Borchard F, Gaco V, Greschniok A, Eckardt VF, Bettendorf U, Gregor M, Porschen R.
    Z Gastroenterol; 1999 Oct 10; 37(10):1005-11. PubMed ID: 10549095
    [Abstract] [Full Text] [Related]

  • 13. [Barrett's esophagus carcinoma].
    Messmann H.
    Praxis (Bern 1994); 2006 Jun 21; 95(25-26):1029-35. PubMed ID: 16836063
    [Abstract] [Full Text] [Related]

  • 14. LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus.
    Dolan K, Garde J, Walker SJ, Sutton R, Gosney J, Field JK.
    Hum Pathol; 1999 Dec 21; 30(12):1508-14. PubMed ID: 10667431
    [Abstract] [Full Text] [Related]

  • 15. [Frequency and significance of APC gene mutations in malignant degeneration of Barrett esophagus].
    Stöltzing O, Schneider PM, Becker K, Wegerer S, Siewert JR, Hölscher AH.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Dec 21; 115(Suppl I):485-9. PubMed ID: 14518303
    [Abstract] [Full Text] [Related]

  • 16. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.
    Lomo LC, Blount PL, Sanchez CA, Li X, Galipeau PC, Cowan DS, Ayub K, Rabinovitch PS, Reid BJ, Odze RD.
    Am J Surg Pathol; 2006 Apr 21; 30(4):423-35. PubMed ID: 16625087
    [Abstract] [Full Text] [Related]

  • 17. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, Burgart LJ, Ahlquist DA.
    Int J Cancer; 2005 Sep 10; 116(4):584-91. PubMed ID: 15825175
    [Abstract] [Full Text] [Related]

  • 18. [Barrett's esophagus].
    Neuhaus H.
    Praxis (Bern 1994); 2004 Nov 17; 93(47):1951-7. PubMed ID: 15656005
    [Abstract] [Full Text] [Related]

  • 19. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma.
    Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG, Blount PL, Reid BJ.
    Cancer Res; 2004 Oct 15; 64(20):7629-33. PubMed ID: 15492292
    [Abstract] [Full Text] [Related]

  • 20. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
    Makita K, Kitazawa R, Semba S, Fujiishi K, Nakagawa M, Haraguchi R, Kitazawa S.
    World J Gastroenterol; 2013 Jan 28; 19(4):536-41. PubMed ID: 23382633
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.